查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
甲状腺眼疾市场报告：2030 年趋势、预测与竞争分析
市场调查报告书
商品编码
1356893

甲状腺眼疾市场报告：2030 年趋势、预测与竞争分析

Thyroid Eye Disease Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

甲状腺眼疾的趋势和预测

预计到 2030 年，全球甲状腺眼疾市场预计将达到 14 亿美元，2024 年至 2030 年年复合成长率为 8.1%。该市场的主要驱动因素是增加自体免疫疾病治疗、提高患者对治疗的依从性以及改善医疗环境。全球甲状腺眼疾市场的未来充满希望，医院和诊所市场充满机会。

甲状腺眼疾市场洞察

  • Lucintel 预测单株抗体将在预测期内达到最高成长。
  • 医院将继续成为该市场的最大细分市场。
  • 由于医疗保健支出增加、疾病数量增加以及该地区主要企业投资增加，预计亚太地区将在预测期内实现最高增长。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和业务风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球甲状腺眼疾市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球甲状腺眼疾市场趋势（2018-2023）与预测（2024-2030）
  • 按治疗类型分類的全球甲状腺眼疾市场
    • 皮质类固醇
    • 维他命
    • 单株抗体
    • 其他的
  • 依给药途径：全球甲状腺眼疾市场
    • 口服
    • 局部的
    • 胃肠外的
  • 按产品：全球甲状腺眼疾市场
    • 锭剂
    • 胶囊
    • 软膏
    • 解决方案
  • 按最终用途行业分類的全球甲状腺眼疾市场
    • 医院
    • 诊所
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 全球甲状腺眼疾市场（按地区）
  • 北美洲甲状腺眼疾市场
  • 欧洲甲状腺眼疾市场
  • 亚太地区甲状腺眼疾市场
  • 其他区域甲状腺眼疾市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
  • 全球甲状腺眼疾市场的新趋势
  • 战略分析
    • 新产品开发
    • 全球甲状腺眼疾市场的产能扩张
    • 全球甲状腺眼疾市场的合併、收购与合资企业
    • 认证和许可

第7章主要企业概况

  • AbbVie
  • Novartis International
  • Teva Pharmaceutical Industries
  • Pfizer
  • Sanofi SA
  • Merck
  • Abbot Laboratories
  • Horizon Therapeutics
  • Johnson & Johnson
  • GE Healthcare
简介目录

Thyroid Eye Disease Trends and Forecast

The future of the global thyroid eye disease market looks promising with opportunities in the hospital and clinic markets. The global thyroid eye disease market is expected to reach an estimated $1.40 billion by 2030 with a CAGR of 8.1% from 2024 to 2030. The major drivers for this market are the growing incidence autoimmune disease treatment, increasing number of patient compliance for treatment, and improved healthcare settings.

A more than 150-page report is developed to help in your business decisions.

Thyroid Eye Disease by Segment

The study includes a forecast for the global thyroid eye disease by treatment type, route of administration, product, end use industry, and region.

Thyroid Eye Disease Market by Treatment Type [Shipment Analysis by Value from 2018 to 2030]:

  • Corticosteroids
  • Vitamins
  • Monoclonal Antibody
  • Others

Thyroid Eye Disease Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:

  • Oral
  • Topical
  • Parenteral

Thyroid Eye Disease Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Tablet
  • Capsule
  • Ointment
  • Solution

Thyroid Eye Disease Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Clinics
  • Others

Thyroid Eye Disease Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Thyroid Eye Disease Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies thyroid eye disease companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the thyroid eye disease companies profiled in this report include-

  • Abbvie
  • Novartis International
  • Teva Pharmaceutical Industries
  • Pfizer
  • Sanofi S.A.
  • Merck
  • Abbot Laboratories
  • Horizon Therapeutics
  • Johnson & Johnson
  • GE Healthcare

Thyroid Eye Disease Market Insights

  • Lucintel forecasts that monoclonal antibody is expected to witness highest growth over the forecast period.
  • Within this market, hospitals will remain the largest segment.
  • APAC is expected to witness highest growth over the forecast period due to increasing healthcare expenditure, rising number of diseases, and rising investments by major players in the region.

Features of the Global Thyroid Eye Disease Market

  • Market Size Estimates: Thyroid Eye Disease Market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
  • Segmentation Analysis: Thyroid Eye Disease Market by various segments, such as by treatment type, route of administration, product, end use industry and region in terms of($B).
  • Regional Analysis: Thyroid Eye Disease Market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different treatment types, route of administrations, products, end use industries, and region.s for the thyroid eye disease market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the thyroid eye disease market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the thyroid eye disease market size?

Answer: The global thyroid eye disease market is expected to reach an estimated $1.40 billion by 2030.

Q.2. What is the growth forecast for thyroid eye disease market?

Answer: The global thyroid eye disease market is expected to grow with a CAGR of 8.1% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the thyroid eye disease market?

Answer: The major drivers for this market are the growing incidence autoimmune disease treatment, increasing number of patient compliance for treatment, and improved healthcare settings.

Q.4. What are the major segments for thyroid eye disease market?

Answer: The future of the thyroid eye disease market looks promising with opportunities in the hospital and clinic markets.

Q.5. Who are the key thyroid eye disease market companies?

Answer: Some of the key thyroid eye disease companies are as follows:

  • AbbVie
  • Novartis International
  • Teva Pharmaceutical Industries
  • Pfizer
  • Sanofi S.A.
  • Merck
  • Abbot Laboratories
  • Horizon Therapeutics
  • Johnson & Johnson
  • GE Healthcare

Q.6. Which thyroid eye disease market segment will be the largest in future?

Answer: Lucintel forecasts that monoclonal antibody is expected to witness highest growth over the forecast period.

Q.7. In thyroid eye disease market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to increasing healthcare expenditure, rising number of diseases, and rising investments by major players in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the thyroid eye disease market by treatment type (corticosteroids, vitamins, monoclonal antibody, and others), route of administration (oral, topical, and parenteral), product (tablet, capsule, ointment, and solution), end use industry (hospitals, clinics, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Thyroid Eye Disease Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Thyroid Eye Disease Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Thyroid Eye Disease Market by Treatment Type
    • 3.3.1: Corticosteroids
    • 3.3.2: Vitamins
    • 3.3.3: Monoclonal Antibody
    • 3.3.4: Others
  • 3.4: Global Thyroid Eye Disease Market by Route of Administration
    • 3.4.1: Oral
    • 3.4.2: Topical
    • 3.4.3: Parenteral
  • 3.5: Global Thyroid Eye Disease Market by Product
    • 3.5.1: Tablet
    • 3.5.2: Capsule
    • 3.5.3: Ointment
    • 3.5.4: Solution
  • 3.6: Global Thyroid Eye Disease Market by End Use Industry
    • 3.6.1: Hospitals
    • 3.6.2: Clinics
    • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Thyroid Eye Disease Market by Region
  • 4.2: North American Thyroid Eye Disease Market
    • 4.2.1: North American Thyroid Eye Disease Market by Treatment Type: Corticosteroids, Vitamins, Monoclonal Antibody, and Others
    • 4.2.2: North American Thyroid Eye Disease Market by End Use Industry: Hospitals, Clinics, and Others
  • 4.3: European Thyroid Eye Disease Market
    • 4.3.1: European Thyroid Eye Disease Market by Treatment Type: Corticosteroids, Vitamins, Monoclonal Antibody, and Others
    • 4.3.2: European Thyroid Eye Disease Market by End Use Industry: Hospitals, Clinics, and Others
  • 4.4: APAC Thyroid Eye Disease Market
    • 4.4.1: APAC Thyroid Eye Disease Market by Treatment Type: Corticosteroids, Vitamins, Monoclonal Antibody, and Others
    • 4.4.2: APAC Thyroid Eye Disease Market by End Use Industry: Hospitals, Clinics, and Others
  • 4.5: ROW Thyroid Eye Disease Market
    • 4.5.1: ROW Thyroid Eye Disease Market by Treatment Type: Corticosteroids, Vitamins, Monoclonal Antibody, and Others
    • 4.5.2: ROW Thyroid Eye Disease Market by End Use Industry: Hospitals, Clinics, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Thyroid Eye Disease Market by Treatment Type
    • 6.1.2: Growth Opportunities for the Global Thyroid Eye Disease Market by Route of Administration
    • 6.1.3: Growth Opportunities for the Global Thyroid Eye Disease Market by Product
    • 6.1.4: Growth Opportunities for the Global Thyroid Eye Disease Market by End Use Industry
    • 6.1.5: Growth Opportunities for the Global Thyroid Eye Disease Market by Region
  • 6.2: Emerging Trends in the Global Thyroid Eye Disease Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Thyroid Eye Disease Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Thyroid Eye Disease Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: AbbVie
  • 7.2: Novartis International
  • 7.3: Teva Pharmaceutical Industries
  • 7.4: Pfizer
  • 7.5: Sanofi S.A.
  • 7.6: Merck
  • 7.7: Abbot Laboratories
  • 7.8: Horizon Therapeutics
  • 7.9: Johnson & Johnson
  • 7.10: GE Healthcare